We are live on ! Find out more
PYXS icon

Pyxis Oncology
PYXS

51 hedge funds and large institutions have $200M invested in Pyxis Oncology in 2021 Q4 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

55.98% more ownership

Funds ownership: 0% → 55.98% (+56%)

Holders
51
Holders Change
+51
Holders Change %
–
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
51
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$26.1M
2
RI
RTW Investments
New York
+$24.3M
3
PA
Perceptive Advisors
New York
+$22.3M
4
BI
BVF Inc
California
+$20.5M
5
Citadel Advisors
Citadel Advisors
Florida
+$17.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$345K +$360K +31,461 New
Squarepoint
27
Squarepoint
New York
$344K +$359K +31,328 New
GCM
28
Ghisallo Capital Management
Massachusetts
$329K +$343K +30,000 New
Bank of America
29
Bank of America
North Carolina
$314K +$328K +28,616 New
Charles Schwab
30
Charles Schwab
California
$254K +$264K +23,094 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$212K +$221K +19,284 New
N
32
Nuveen
North Carolina
$177K +$185K +16,163 New
Walleye Capital
33
Walleye Capital
New York
$175K +$182K +15,933 New
Tudor Investment Corp
34
Tudor Investment Corp
Connecticut
$149K +$156K +13,624 New
JP Morgan Chase
35
JP Morgan Chase
New York
$129K +$135K +11,769 New
Wells Fargo
36
Wells Fargo
California
$125K +$131K +11,414 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$114K +$119K +10,367 New
Millennium Management
38
Millennium Management
New York
$112K +$117K +10,253 New
SIM
39
Sandia Investment Management
Massachusetts
$110K +$114K +10,000 New
DKCM
40
Davidson Kempner Capital Management
New York
$109K +$114K +10,000 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$69K +$71.9K +6,277 New
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$64K +$67K +5,856 New
AIG
43
American International Group
New York
$62K +$64.7K +5,650 New
UBS Group
44
UBS Group
Switzerland
$53K +$55.2K +4,818 New
Citigroup
45
Citigroup
New York
$35K +$36.7K +3,206 New
Morgan Stanley
46
Morgan Stanley
New York
$31K +$32.4K +2,832 New
SO
47
STRS Ohio
Ohio
$27K +$28.6K +2,500 New
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$23K +$24.5K +2,136 New
Legal & General Group
49
Legal & General Group
United Kingdom
$11K +$11.2K +975 New
AIP
50
Ameritas Investment Partners
Nebraska
$9K +$9.41K +822 New
1
2
3

PYXS Hedge Fund Activity: Q4 2021 in Review

51 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Pyxis Oncology (PYXS) for Q4 2021, worth a combined $200M.

Buyers outnumbered sellers: 51 funds opened new PYXS positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $26.1M.

  • 51 institutional investors held Pyxis Oncology (PYXS) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $200M of Pyxis Oncology stock for Q4 2021.
  • 51 funds opened new Pyxis Oncology positions in Q4 2021 and 0 closed out, a net change of +51 holders.
  • The largest Pyxis Oncology buyer in Q4 2021 was RA Capital Management, an estimated $26.1M added.

Based on aggregated 13F filings for Q4 2021.